Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug ...
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Recorded last week at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with Kristen ...
How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.
REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief ...
Develops monoclonal antibodies (e.g. Sotrovimab/Xevudy for COVID-19), RNAi therapeutics for hepatitis B, and investigational therapies for influenza A and HIV. Generates revenue through product sales, ...
From Eli Lilly's David Ricks to Pfizer's Albert Bourla, the top five highest paid CEOs made a combined $157.8 million in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results